Richard W Bock

US Patent:

D456841, May 7, 2002

Filed:

Apr 9, 2001

Appl. No.:

29/139938

Inventors:

Richard Bock - Santa Monica CA 90402

International Classification:

1904

US Classification:

D19 26

US Patent:

20020145280, Oct 10, 2002

Filed:

Apr 9, 2001

Appl. No.:

09/829041

Inventors:

Richard Bock - Santa Monica CA, US

International Classification:

B42D001/00
B42D005/00
B42D009/00

US Classification:

281/015100

Abstract:

The current invention is a fold-open, clipboard-sized medical folder, made of leather or vinyl over reinforced cardboard, which holds a paper medical record (or other document) on one side and an electronic computer device on the other. It is designed to facilitate the incremental transition from paper to electronic record keeping. Both paper document and electronic device are removable to allow for separate movement throughout the office. The invention has a series of 3-4 “flags” mounted as colored pull tabs or on/off, colored lights visible on the lateral external surface, for use as interoffice alerts and in chart routing instructions.

US Patent:

20090202467, Aug 13, 2009

Filed:

Dec 15, 2008

Appl. No.:

12/335084

Inventors:

Richard W. Bock - Asheville NC, US

International Classification:

A61K 31/77
C08G 65/04
A61P 9/00

US Classification:

424 7838, 525 93, 521149

Abstract:

This invention is directed to pharmaceutical compositions and methods of treating varicose veins, including telangiectasias and reticular veins, and related symptoms and diseases. Embodiments comprise injection into a varicose vein of an amphiphilic block copolymer which has properties of conversion from liquid to gel state, surfactant properties, or combinations thereof. Other embodiments consist of the combination of an amphiphilic block copolymer with a co-solvent, also allowing the injected combination to form a gel within the vein. In other embodiments, an amphiphilic block copolymer is combined with a co-solvent, a sclerosant, a vasoconstrictor, water, or combinations thereof. Other embodiments of the invention include a combination of a sclerosant such as sodium tetradecyl sulfate or polidocanol with a vasoconstrictor, preferably a long-acting vasoconstrictor such as oxymetazoline. Other embodiments are directed to compositions and methods of treating venous and arteriovenous malformations and cancer.